[ad_1]
Austin tech companies brought in new funding in September to help grow their teams and advance their technologies. The month’s five major funding rounds will be used to help stroke survivors, develop more sophisticated satellite imagery and increase access to particle accelerators. Keep reading to see which Austin companies attracted the most funding in September.
#5. Kizen: 12 million dollars, September 13
Kizen, a no-code enterprise software company, has developed A sales CRM platform that helps align teams while automating up to 10 hours a week of non-sales tasks. Kizen Operations Cloud, meanwhile, helps operations teams unify data, customize workflows, and automate processes. The seed money will be used to expand marketing and sales campaigns while supporting new product features.
#4. TAU Systems: $15 million, September 26
TAU Systems, which was spun out of the University of Texas at Austin, is developing affordable particle blowers that can be as small as a table or 20 to 30 meters across. These particle accelerators can produce X-ray free electron lasers (XFELs) that allow researchers to perform molecular or atomic analysis in the fields of biotech, chemistry or materials science. The company will use the newly acquired seed funding to develop industrial prototypes. The company plans to offer XFEL analysis as a service in 2026 and start selling XFEL systems as a product in 2027.
#3. Form Bio: $30 million, September 27
Colossal Biosciences, a biotech startup, has identified a gap in the life science software market and launched FormBion, which aims to bring the woolly mammoth and Tasmanian tiger back from extinction. The new company has raised a $30 million Series A round to develop AI-based software that helps life scientists manage large data sets, create workflows and collaborate with colleagues. The company says the platform can be used for drug discovery, manufacturing efficiency and other endeavors.
#2. Albedo: $48 million, September 7
Albedo is operating ultra-low-Earth-orbit satellites to collect 10-centimeter spectral images, which will be illegal for commercial use until May 2020. First, develop the necessary software to support satellite and satellite operations and deliver images to users.
#1. MicroTransporter: $73 million, September 21
Microtransponder has developed technology to help stroke survivors regain upper limb function. The company said this. Oversubscribed Series E funding FDA-approved to support the development and commercialization of Vivistim, a neurostimulation device that uses vagus nerve stimulation (VNS) during rehabilitation therapy to improve hand and hand function by two to three times.
[ad_2]
Source link
